sb 203580 has been researched along with fibrin in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (fibrin) | Trials (fibrin) | Recent Studies (post-2010) (fibrin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 15,994 | 328 | 3,808 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XH; Han, YL; Kang, J; Liang, M; Qi, YM | 1 |
| Bergeron, A; Brezai, A; Calderone, A; Gillis, MA; Hertig, V; Villeneuve, L | 1 |
2 other study(ies) available for sb 203580 and fibrin
| Article | Year |
|---|---|
[Role of MAPK in the migration of human coronary artery smooth muscle cell into three-dimensional fibrin gel].
Topics: Anthracenes; Cell Movement; Cells, Cultured; Coronary Vessels; Extracellular Signal-Regulated MAP Kinases; Fibrin; Flavonoids; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Pyridines | 2005 |
p38α MAPK inhibition translates to cell cycle re-entry of neonatal rat ventricular cardiomyocytes and de novo nestin expression in response to thrombin and after apex resection.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Cell Cycle; Cell Division; Fibrin; Heart Ventricles; Imidazoles; Mitogen-Activated Protein Kinase 14; Myocytes, Cardiac; Nestin; Phosphorylation; Pyridines; Rats; Signal Transduction; Thrombin | 2019 |